Comparison of current guidelines and consensus on the management of patients with cholangiocarcinoma: 2022 update
Intractable & Rare Diseases Research · 30.11.2022 · 11 (4) · 161-172
DOI: 10.5582/irdr.2022.01109 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Intractable & Rare Diseases Research, erschienen am 30.11.2022. Verfasst von Xinyi Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biliary Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Biliary Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zitieren
APA
Zhang, X., Cai, Y., Xiong, X., Liu, A., Zhou, R., You, Z., Li, F., & Cheng, N. (2022). Comparison of current guidelines and consensus on the management of patients with cholangiocarcinoma: 2022 update. Intractable & Rare Diseases Research, 11(4), 161-172. https://doi.org/10.5582/irdr.2022.01109
Vancouver
Zhang X, Cai Y, Xiong X, Liu A, Zhou R, You Z, et al. Comparison of current guidelines and consensus on the management of patients with cholangiocarcinoma: 2022 update. Intractable & Rare Diseases Research. 2022;11(4):161-172. doi:10.5582/irdr.2022.01109
BibTeX
@article{Zhang2022,
author = {Zhang, Xinyi and Cai, Yulong and Xiong, Xianze and Liu, Ao and Zhou, Rongxin and You, Zhen and Li, Fuyu and Cheng, Nansheng},
title = {Comparison of current guidelines and consensus on the management of patients with cholangiocarcinoma: 2022 update},
journal = {Intractable & Rare Diseases Research},
year = {2022},
volume = {11},
number = {4},
pages = {161--172},
doi = {10.5582/irdr.2022.01109}
}
EUVIMED